Depression and subsequent risk of Parkinson disease
A nationwide cohort study
Abstract
Objective:
To investigate the long-term risk of Parkinson disease (PD) after depression and evaluate potential confounding by shared susceptibility to the 2 diagnoses.
Methods:
The nationwide study cohort included 140,688 cases of depression, matched 1:3 using a nested case-control design to evaluate temporal aspects of study parameters (total, n = 562,631). Potential familial coaggregation of the 2 diagnoses was investigated in a subcohort of 540,811 sibling pairs. Associations were investigated using multivariable adjusted statistical models.
Results:
During a median follow-up period of 6.8 (range, 0–26.0) years, 3,260 individuals in the cohort were diagnosed with PD. The multivariable adjusted odds ratio (OR) for PD was 3.2 (95% confidence interval [CI], 2.5–4.1) within the first year of depression, decreasing to 1.5 (95% CI, 1.1–2.0) after 15 to 25 years. Among participants with depression, recurrent hospitalization was an independent risk factor for PD (OR, 1.4; 95% CI, 1.1–1.9 for ≥5 vs 1 hospitalization). In family analyses, siblings' depression was not significantly associated with PD risk in index persons (OR, 1.1; 95% CI, 0.9–1.4).
Conclusions:
The time-dependent effect, dose-response pattern for recurrent depression, and lack of evidence for coaggregation among siblings all indicate a direct association between depression and subsequent PD. Given that the association was significant for a follow-up period of more than 2 decades, depression may be a very early prodromal symptom of PD, or a causal risk factor.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
File (6.16.15_depression_and_subsequent_risk_of_pd.pdf)
- Download
- 426.00 KB
REFERENCES
1.
Lieberman A. Depression in Parkinson's disease: a review. Acta Neurol Scand 2006;113:1–8.
2.
Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008;23:183–189.
3.
Frisina PG, Borod JC, Foldi NS, Tenenbaum HR. Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat 2008;4:81–91.
4.
Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006;113:211–220.
5.
Taylor CA, Saint-Hilaire MH, Cupples LA, et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999;88:742–749.
6.
Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669–677.
7.
Schuurman AG, van den Akker M, Ensinck KT, et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 2002;58:1501–1504.
8.
Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003;18:414–418.
9.
Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001;104:380–386.
10.
Li X, Sundquist J, Hwang H, Sundquist K. Impact of psychiatric disorders on Parkinson's disease: a nationwide follow-up study from Sweden. J Neurol 2008;255:31–36.
11.
Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Use of antidepressants and the risk of Parkinson's disease: a prospective study. J Neurol Neurosurg Psychiatry 2009;80:671–674.
12.
Fang F, Xu Q, Park Y, et al. Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010;25:1157–1162.
13.
Shen CC, Tsai SJ, Perng CL, Kuo BI, Yang AC. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology 2013;81:1538–1544.
14.
Jacob EL, Gatto NM, Thompson A, Bordelon Y, Ritz B. Occurrence of depression and anxiety prior to Parkinson's disease. Parkinsonism Relat Disord 2010;16:576–581.
15.
Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry 2007;64:1385–1392.
16.
Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011;26(suppl 1):S1–S58.
17.
Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283–2301.
18.
Marek K, Jennings D. Can we image premotor Parkinson disease? Neurology 2009;72(7 suppl):S21–S26.
19.
Hawkes CH. The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it? Mov Disord 2008;23:1799–1807.
20.
Swedish National Board of Health and Welfare. The National Patient Register. Available at: http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish. Accessed August 26, 2014.
21.
Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish National Inpatient Register. BMC Public Health 2011;11:450.
22.
Swedish National Board of Health and Welfare. Dödsorsaksregistret [in Swedish]. Available at: http://www.socialstyrelsen.se/register/dodsorsaksregistret. Accessed August 26, 2014.
23.
Statistics Sweden. Multi-Generation Register 2010: A Description of Contents and Quality. Örebro: Statistics Sweden; 2011.
24.
Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005;36:1330–1340.
25.
Seel RT, Kreutzer JS, Rosenthal M, Hammond FM, Corrigan JD, Black K. Depression after traumatic brain injury: a National Institute on Disability and Rehabilitation Research Model Systems multicenter investigation. Arch Phys Med Rehabil 2003;84:177–184.
26.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–1078.
27.
Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse 1995;7:481–497.
28.
Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995;39:197–206.
29.
Gilman SE, Abraham HD. A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend 2001;63:277–286.
30.
Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175–2197.
31.
Lin HL, Lin HC, Chen YH. Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study. Ann Epidemiol 2014;24:206–213.
32.
Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003;18:646–651.
33.
Bower JH, Grossardt BR, Maraganore DM, et al. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010;25:2105–2113.
34.
Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and regression dilution bias. BMJ 2010;340:c2289.
35.
Bschor T, Bauer M, Adli M. Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int 2014;111:766–775.
36.
Marston L, Nazareth I, Petersen I, Walters K, Osborn DP. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 2014;4:e006135.
37.
Chabolla DR, Maraganore DM, Ahlskog JE, O'Brien PC, Rocca WA. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clin Proc 1998;73:724–727.
Information & Authors
Information
Published In
Copyright
© 2015 American Academy of Neurology.
Publication History
Received: November 11, 2014
Accepted: March 9, 2015
Published online: May 20, 2015
Published in print: June 16, 2015
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
Study Funding
The study was funded by the Swedish Research Council. The funding bodies did not have a role in the design, writing, or decision to publish the manuscript.
Authors
Author Contributions
P.N. and A.N. conceived the idea for the study. H.G. compiled and analyzed the data, and made initial drafts of tables and figures with input from P.N. H.G. led the writing of the manuscript with contribution from all other authors.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Long-term Intracerebroventricular Administration of Ouabain Causes Motor Impairments in C57Bl/6 Mice, Annals of Clinical and Experimental Neurology, 17, 4, (40-51), (2024).https://doi.org/10.54101/ACEN.2023.4.5
- The effects of physical activity on glutamate neurotransmission in neuropsychiatric disorders, Frontiers in Sports and Active Living, 5, (2023).https://doi.org/10.3389/fspor.2023.1147384
- Bidirectional Mendelian randomization study of psychiatric disorders and Parkinson’s disease, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1120615
- Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence, Current Neuropharmacology, 21, 3, (560-577), (2023).https://doi.org/10.2174/1570159X20666221005090126
- Identification of potential immune-related hub genes in Parkinson’s disease based on machine learning and development and validation of a diagnostic classification model, PLOS ONE, 18, 12, (e0294984), (2023).https://doi.org/10.1371/journal.pone.0294984
- Bayesian network modeling of risk and prodromal markers of Parkinson’s disease, PLOS ONE, 18, 2, (e0280609), (2023).https://doi.org/10.1371/journal.pone.0280609
- Depression as a Prodromal Symptom of Neurodegenerative Diseases, Journal of Nippon Medical School, 90, 2, (157-164), (2023).https://doi.org/10.1272/jnms.JNMS.2023_90-216
- Clinical characteristics and potential association to Parkinson’s disease and dementia with Lewy bodies in patients with major depressive disorder who received maintenance electroconvulsive therapy: a retrospective chart review study, BMC Psychiatry, 23, 1, (2023).https://doi.org/10.1186/s12888-023-04743-7
- Familial α-synucleinopathy spectrum features in patients with psychiatric REM sleep behaviour disorder, Journal of Neurology, Neurosurgery & Psychiatry, 94, 11, (893-903), (2023).https://doi.org/10.1136/jnnp-2022-330922
- Age or age of onset: which is the best criterion to classify late-life depression?, International Clinical Psychopharmacology, 38, 4, (223-230), (2023).https://doi.org/10.1097/YIC.0000000000000472
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.